When was Axitinib/Axitinib launched in China?

Axitinib/Axitinibin2012year1Month27 was approved by the USFDA for marketing. axitinib/axitinibin2015year4(CFDA) on March 29. Axitinib is an oral VEGFR and kinase inhibitor indicated for the treatment of advanced renal cell carcinoma (RCC) after failure of prior systemic therapy.

Axitinib is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). Tyrosine kinase inhibitors work by stopping certain proteins (called tyrosine kinases) from acting on cells. Tyrosine kinases send growth signals to cancer cells. Axitinib blocks different types of tyrosine kinases and is known as a multikinase inhibitor. In addition to slowing the growth of cancer cells, it also prevents cancer cells from forming blood vessels, which cancer needs to grow. This is called an anti-angiogenic treatment.

Axitinib/AxitinibAvoid grapefruit products, Grapefruit inhibitsCYP3A4 metabolism, which may increase the serum concentration of axitinib. Hypericum perforatum should be avoided as this herb induces CYP3A4 metabolism, which may reduce axitinib serum concentrations. Axitinib is a kinase inhibitor. The chemical name of axitinib isn-methyl-2-[3-((E)-2-Pyridine-2-yl-vinyl)-1H-indazole-6-ylsulfanyl]-Benzamide. The molecular formula is C22H18N4OS and the molecular weight is 386.47 Daltons. Overseas generic drugs are available in Bangladesh, and the retail price of Bangladeshi Beacon Pharmaceutical is about 5mg 60 tablets 1800 yuan. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to help you learn more about high-quality overseas drugs.

xa0